List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 10 studies with search of: Open Studies | "Epistaxis"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Conditions: Epistaxis;   Hereditary Hemorrhagic Telangiectasia
Intervention: Drug: Sodium tetradecyl sulfate (sotradecol)
2 Recruiting North American Study of Epistaxis in HHT
Conditions: Telangiectasia, Hereditary Hemorrhagic;   Epistaxis
Interventions: Drug: Sterile saline;   Drug: Bevacizumab;   Drug: Estriol;   Drug: Tranexamic Acid
3 Recruiting Floseal Treatment for Posterior Epistaxis Study
Condition: Epistaxis
Intervention: Drug: Floseal
4 Unknown † A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children
Condition: Epistaxis
Intervention: Procedure: Nasal Cautery
5 Recruiting Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: HHT;   Morbus Osler;   Epistaxis
Interventions: Drug: Bevacizumab;   Drug: NaCl
6 Recruiting Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
7 Recruiting The Effect of Packing in Post Operative Management of FESS
Conditions: Epistaxis;   Nasal Obstruction;   Pain
Intervention: Procedure: packing
8 Recruiting Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Submucosal Bevacizumab
9 Recruiting Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Bevacizumab
10 Recruiting The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services